FIELD: medicinal sealing materials. SUBSTANCE: fibrin sealer, in particular, thrombin-free composition containing fibrin monomer or composition containing non-cross-linking fibrin is applied by bringing it into contact with required area. In this procedure, fibrin monomer converts into fibrin polymer thereby manifesting sealing effect. Thrombin-free aqueous composition containing non-cross-linking fibrin is used in concentration 10 to 200 mg/ml. EFFECT: avoided risk of viral infection or other adverse effects. 70 cl, 1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOASSAY OF SOLUBLE FIBRIN POLYMERS | 1994 |
|
RU2173347C2 |
| DEVICE FOR SEPARATION OF SAMPLE OF LIQUID, METHOD OF SEPARATION OF SAMPLE OF LIQUID, METHOD OF SEPARATION OF LIQUID INTO TWO OR MORE COMPONENTS; RINGS; RING UNIT; METHOD OF SEPARATION OF BLOOD COMPONENT FROM SAMPLE OF LIQUID; METHOD OF OBTAINING FIBRIN-MONOMER FROM BLOOD | 1994 |
|
RU2133468C1 |
| ISOXAZOLE PHENYLSULFONAMIDE DERIVATIVES AND METHOD OF MEDICAL TREATMENT | 1993 |
|
RU2133742C1 |
| HARD BANDAGE FOR TREATMENT OF INJURED TISSUE | 2007 |
|
RU2480191C2 |
| FIBRINOGEN CONTENT ANALYSIS | 2012 |
|
RU2619256C2 |
| METHOD OF FIBRIN CLOT ADMINISTRATION (ITS VARIANTS) AND AGENT KIT FOR ITS ADMINISTRATION (VARIANTS) | 1991 |
|
RU2104701C1 |
| METHOD FOR DETERMINING FIBRINOGEN DURING RECALCIFICATION OF CITRATE PLASMA AND EVALUATING ITS FUNCTIONALITY | 2019 |
|
RU2703541C1 |
| METHOD FOR PRODUCING AUTOLOGOUS FIBRIN WITH CONTROLLED FIBRINOGEN CONTENT WITHOUT USING EXOGENOUS THROMBIN | 2020 |
|
RU2758260C1 |
| SURGICAL TREATMENT OF PLEURAL EMPYEMA WITH BRONCHOPLEURAL FISTULA | 2022 |
|
RU2802125C1 |
| BIOGEL | 2007 |
|
RU2503464C2 |
